|
(BS68) |
Acute infusion of levosimendan enhances atrial fibrillation in an experimental whole-heart model |
| |
|
G. Frommeyer, A. Kohnke, C. Ellermann, D. Dechering, S. Kochhäuser, F. Reinke, L. Eckardt (Münster) |
|
(BS69) |
Bioenergetic properties of levosimendan and omecamtiv mecarbil in guinea-pig cardiac myocytes |
| |
|
D. Pütz, M. Kohlhaas, A. Nickel, C. Maack (Homburg/Saar) |
|
(BS70) |
Rivaroxaban improves cardiac function by reducing early cardiac remodeling after left anterior descending artery (LAD) ligation in mice |
| |
|
M. Bode, W. Bode, R. Vora, B. Cooley, N. Mackman (Chapel Hill, US) |
|
(BS71) |
Ranolazine reduces cardiac remodeling by inhibiting apoptosis in a rat model of chronic myocardial infarction |
| |
|
F. Hemm, T. Ruf, D. M. Poitz, A. Augstein, A. Schauer, R. H. Strasser (Dresden) |
|
(BS72) |
Antiarrhythmic effects of dantrolene in human cardiomyocytes from patients with atrial fibrillation or heart failure |
| |
|
N. Hartmann, S. Pabel, J. Herting, T. H. Fischer, H. Schotola, N. Frey, G. Hasenfuß, S. T. Sossalla (Göttingen, Kiel) |
|
(BS73) |
New targets for old drugs: atrial-specific K2P3.1 (TASK-1) currents are blocked by cardiac glycosides |
| |
|
F. Wiedmann, A.-R. Gaubatz, A. Ratte, H. A. Katus, D. Thomas, C. Schmidt (Heidelberg) |